146 related articles for article (PubMed ID: 17335982)
1. Retention and illicit drug use among methadone patients in Israel: a gender comparison.
Schiff M; Levit S; Moreno RC
Addict Behav; 2007 Oct; 32(10):2108-19. PubMed ID: 17335982
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
[TBL] [Abstract][Full Text] [Related]
3. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
4. Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic.
Peles E; Adelson M
J Addict Dis; 2006; 25(2):39-45. PubMed ID: 16785218
[TBL] [Abstract][Full Text] [Related]
5. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
Maremmani I; Pani PP; Pacini M; Perugi G
J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
[TBL] [Abstract][Full Text] [Related]
6. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
[TBL] [Abstract][Full Text] [Related]
7. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
8. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
[TBL] [Abstract][Full Text] [Related]
9. Predictors of retention in methadone programs: a signal detection analysis.
Villafranca SW; McKellar JD; Trafton JA; Humphreys K
Drug Alcohol Depend; 2006 Jul; 83(3):218-24. PubMed ID: 16384657
[TBL] [Abstract][Full Text] [Related]
10. Predictors of patient retention in a newly established methadone maintenance treatment programme.
del Rio M; Mino A; Perneger TV
Addiction; 1997 Oct; 92(10):1353-60. PubMed ID: 9489052
[TBL] [Abstract][Full Text] [Related]
11. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
[TBL] [Abstract][Full Text] [Related]
12. Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT).
Peles E; Schreiber S; Adelson M
Eur Neuropsychopharmacol; 2008 Mar; 18(3):188-93. PubMed ID: 17997285
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of mental and physical health disorders among older methadone patients.
Rosen D; Smith ML; Reynolds CF
Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
[TBL] [Abstract][Full Text] [Related]
15. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
Stitzer ML; Peirce J; Petry NM; Kirby K; Roll J; Krasnansky J; Cohen A; Blaine J; Vandrey R; Kolodner K; Li R
Exp Clin Psychopharmacol; 2007 Aug; 15(4):344-50. PubMed ID: 17696681
[TBL] [Abstract][Full Text] [Related]
16. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
17. [Factors influencing the rate on retention to methadone maintenance treatment program among heroin addicts in Guizhou, China].
Liang T; Liu EW; Zhong H; Wang B; Shen LM; Wu ZL
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):131-5. PubMed ID: 19565871
[TBL] [Abstract][Full Text] [Related]
18. [Study on the time of retention and related influencing factors of patients receiving methadone maintenance treatment in Hunan province].
Li XL; Tan HZ; Sun ZQ; Zhang H; Chen MS; Ou QY
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):672-5. PubMed ID: 19957587
[TBL] [Abstract][Full Text] [Related]
19. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
20. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
